Zinzino: ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2023
Zinzino group revenue increased with a total of 22 %, compared with the previous year.
The revenue in October for Zinzino's sales markets increased by 22 % and amounted to SEK 156.2 (128.5) million. Faun Pharma's external sales increased by 20 % and amounted to SEK 5.9 (4.9) million. Overall, the Group increased revenues by 22 % to SEK 162.1 (133.4) million compared with the previous year.
Accumulated revenue for January - October 2023 increased by 22 % to SEK 1400.5 (1147.2) million.
Revenues were distributed as follows:
Regions,MSEK 23 22-Oct Change YTD 2023 YTD 2022 Change
-Oct
The Nordics 27.3 28.5 -4% 244.3 264.2 -8%
Central 41.1 27.8 48% 344.1 224.3 53%
Europe
East Europe 30.5 30.3 1% 311.8 268.1 16%
South & West 28.1 16.1 75% 208.3 130.1 60%
Europe
The Baltics 8.7 7,0 24% 75.4 59.6 27%
North 16.2 11.6 40% 84,0 63.6 32%
America
Asia-Pacific 3.5 6.1 -43% 44.6 63.8 -30%
Africa 0.8 1.1 -27% 10.8 7.3 48%
Zinzino 156.2 128.5 22% 1323.3 1 081,0 22%
Faun Pharma 5.9 4.9 20% 77.2 66.2 17%
Zinzino 162.1 133.4 22% 1400.5 1147.2 22%
Group
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser:
Erik Penser Bank Aktiebolag